You are here

Novartis

Pharma's Most Perilous Pipelines

Motley Fool

Sat, 04/23/11 - 10:58 am

Teva Pharmaceuticals

Crunching the Data: Seven Big Pharmas With Consistent Dividends

Seeking Alpha

Fri, 04/22/11 - 07:54 am

Abbott Laboratories

Bristol-Myers Squibb

Teva: Fallen Angel Looking Up?

Seeking Alpha

Thu, 04/21/11 - 06:52 pm

Teva Pharmaceuticals

Titan Should Be on the Biotech Watch Lists Right Now

Seeking Alpha

Thu, 04/21/11 - 09:54 am

Roche's Genentech Sues Novartis Unit Claiming Infringement of Valcyte Drug

Bloomberg

Thu, 04/21/11 - 09:23 am

Mylan now selling generic version of Novartis' herpes drug Famvir

Yahoo/AP

Wed, 04/20/11 - 12:01 pm

Novartis Profit Falls 4%, Sales Rise 16%

Tue, 04/19/11 - 10:05 pm

Drug maker Novartis' Q1 earnings down 6 percent

Yahoo/AP

Tue, 04/19/11 - 09:52 am

Proteon Therapeutics advances drug candidate, sale to Novartis

Bizjournals.com

Thu, 04/14/11 - 06:18 pm

chronic kidney disease

Vanda: Growth Potential With Fanapt Depot Formulation Now in Trial

Seeking Alpha

Wed, 04/13/11 - 07:54 am

A Double Dose of Trouble for Big Pharma?

Motley Fool

Mon, 04/11/11 - 05:00 pm

pancreatic tumors

Novartis ends Tasigna trial in intestinal cancer

Yahoo/AP

Mon, 04/11/11 - 12:39 pm

intestinal cancer

Novartis shareholders approve Alcon deal

BusinessWeek

Sun, 04/10/11 - 03:22 pm

Don’t Talk to Me About Financials, Says Novartis R&D Head.

WSJ

Sat, 04/9/11 - 11:15 am

Alcon Shareholders Approve Merger with Novartis

Thu, 04/7/11 - 09:09 pm

Alcon shareholders approve sale to Novartis

Yahoo/AP

Thu, 04/7/11 - 05:16 pm

Novartis sells skin drug to Meda for $420 mln

Reuters

Thu, 04/7/11 - 01:42 pm

Novartis Aims to Resurrect ‘Zombie’ Drug After Four Years

Bloomberg

Wed, 04/6/11 - 08:17 am

On Novartis's Patent Dispute in India

Seeking Alpha

Wed, 04/6/11 - 08:14 am

The Incredible Shrinking Eye Care Sector

Seeking Alpha

Tue, 04/5/11 - 10:40 pm

Pages